Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

P53 alterations in bladder tumors from arsenic and tobacco exposed patients.

Carcinogenesis - 1 Nov 2003

Moore Lee E, Smith Allan H, Eng Clarence, DeVries Sandy, Kalman Dave, Bhargava Vivek, Chew Karen, Ferreccio Catterina, Rey Omar A, Hopenhayn Claudia, Biggs Mary Lou, Bates Michael N, Waldman Frederic M

Abstract excerpt

Previous studies demonstrated that tobacco and arsenic exposure are risk factors for bladder cancer. A case-case study was conducted to compare p53 mutations in 147 bladder tumors from South American patients by tobacco and arsenic exposure. Information on residential history and lifestyle factors was collected. The prevalence of p53 mutations and protein expression was examined in relation to tumor stage, grade,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arsenic
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Environmental Exposure

Share to Genes, p53

Share to Immunohistochemistry

Share to Risk Factors

Share to Tobacco Products

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 12919957
DOI: 10.1093/carcin/bgg136

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

P53 alterations in bladder tumors from arsenic and tobacco exposed patients.PMID 12919957Read ↗

TP53 alterations and patterns of carcinogen exposure in a U.S. population-based study of bladder cancer.Semantic proximity Read ↗

Arsenic-Related Chromosomal Alterations in Bladder CancerSemantic proximity Read ↗

A molecular and epidemiological study on bladder cancer: p53 mutations, tobacco smoking, and occupational exposure to asbestos.Semantic proximity Read ↗

Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers.Semantic proximity Read ↗

Carcinogen exposure and gene promoter hypermethylation in bladder cancer.Semantic proximity Read ↗

p53 mutations in cyclophosphamide-associated bladder cancer.Semantic proximity Read ↗

Carcinogen Exposure and Epigenetic Silencing in Bladder CancerSemantic proximity Read ↗

A case-control study of polymorphisms in xenobiotic and arsenic metabolism genes and arsenic-related bladder cancer in New Hampshire.Semantic proximity Read ↗

p53 mutations in bladder cancer: evidence for exogenous versus endogenous risk factors.Semantic proximity Read ↗

Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage.Semantic proximity Read ↗

Comparison of genome-wide DNA methylation in urothelial carcinomas of patients with and without arsenic exposureSemantic proximity Read ↗

Mutational spectrum in the p53 gene in bladder tumors from the endemic area of black foot disease in Taiwan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.